Gerresheimer AG (ETR:GXI – Get Free Report)’s share price shot up 0.1% during mid-day trading on Wednesday. The company traded as high as €32.78 and last traded at €32.76. 220,290 shares were traded during trading, an increase of 56% from the average daily volume of 140,925 shares. The stock had previously closed at €32.72.
Gerresheimer Trading Down 0.2%
The company has a market cap of $1.10 billion, a price-to-earnings ratio of 9.59, a P/E/G ratio of 0.82 and a beta of 0.48. The firm has a fifty day moving average price of €28.07 and a 200 day moving average price of €26.41. The company has a debt-to-equity ratio of 230.56, a quick ratio of 0.40 and a current ratio of 1.07.
About Gerresheimer
Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The company offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and glass bottles and jars, as well as caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery systems, including inhalers, injection/auto injectors, pen injectors, infusion systems, and inhalation assessment, autoinjector, and other services.
Further Reading
- Five stocks we like better than Gerresheimer
- Spotify Soars After Earnings as the Company Touts AI Benefits and Moderating Costs
- Lockheed Martin’s Record $292 Billion Backlog Comes With a Delivery Test
- Palantir’s Next Big Test Isn’t a Partnership—It’s the Numbers
- Kinder Morgan’s $4.7 Billion Pipeline Bet Could Be Bigger Than Its Earnings Beat
Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.
